tetano
Editor, Senior Moderator
Rev Peru Med Exp Salud Publica. 2019 Jul-Sep;36(3):511-514. doi: 10.17843/rpmesp.2019.363.4481. Epub 2019 Dec 2. [h=1][Surveillance, prevention, and control of influenza virus in Peru].[/h]
[Article in Spanish; Abstract available in Spanish from the publisher]
Laguna-Torres VA[SUP]1[/SUP], G?mez J[SUP]2[/SUP], Hern?ndez H[SUP]3[/SUP], Francia-Romero J[SUP]4[/SUP], Bisso-Andrade A[SUP]5[/SUP], Guerreros A[SUP]6[/SUP], Cerna-Barco J[SUP]7[/SUP], Sanchez-Vergaray E[SUP]8,[/SUP][SUP]9[/SUP], Gotuzzo E[SUP]10[/SUP].
[h=3]Author information[/h] 1 Instituto de Medicina Tropical Daniel Carri?n. Universidad Nacional Mayor de San Marcos. Lima, Per?. 2 Cl?nica San Pablo. Lima, Per?. 3 Universidad Peruana Cayetano Heredia. Lima, Per?. 4 Sociedad Peruana de Salud Ocupacional Lima, Peru. 5 Sociedad Peruana de Medicina Interna. Lima, Per?. 6 Cl?nica Internacional. Lima, Per?. 7 Hospital Edgardo Rebagliatti Martins, Essalud. Lima Per?. 8 Hospital Nacional Hip?lito Unanue. Lima, Per?. 9 Sociedad Peruana de Enfermedades Infecciosas y Tropicales. Lima, Per?. 10 Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia. Lima, Per?.
[h=3]Abstract[/h] in English, Spanish
The importance of surveilling the circulation of the influenza virus and timely vaccination of different populations in Peru was analyzed in three sessions by a group of clinical experts from different specialties. The Peruvian national influenza surveillance system has many selected establishments that have become currently ineffective in terms of a timely report. Most of the samples come from Lima. The viral distribution is inadequately analyzed. The northern and jungle areas of the country have weather and season conditions different to those in Lima and on the southern highlands. This lack of coordination is accentuated by the opportunity of arrival of the influenza vaccine in the country. The Ministry of Health uses a trivalent vaccine but the possibility of a tetravalent vaccine with the two type-B lineages must be analyzed from a cost-benefit standpoint. The appropriateness of vaccinating two times a year, regionally, should be assessed.
PMID: 31800947 DOI: 10.17843/rpmesp.2019.363.4481
[Article in Spanish; Abstract available in Spanish from the publisher]
Laguna-Torres VA[SUP]1[/SUP], G?mez J[SUP]2[/SUP], Hern?ndez H[SUP]3[/SUP], Francia-Romero J[SUP]4[/SUP], Bisso-Andrade A[SUP]5[/SUP], Guerreros A[SUP]6[/SUP], Cerna-Barco J[SUP]7[/SUP], Sanchez-Vergaray E[SUP]8,[/SUP][SUP]9[/SUP], Gotuzzo E[SUP]10[/SUP].
[h=3]Author information[/h] 1 Instituto de Medicina Tropical Daniel Carri?n. Universidad Nacional Mayor de San Marcos. Lima, Per?. 2 Cl?nica San Pablo. Lima, Per?. 3 Universidad Peruana Cayetano Heredia. Lima, Per?. 4 Sociedad Peruana de Salud Ocupacional Lima, Peru. 5 Sociedad Peruana de Medicina Interna. Lima, Per?. 6 Cl?nica Internacional. Lima, Per?. 7 Hospital Edgardo Rebagliatti Martins, Essalud. Lima Per?. 8 Hospital Nacional Hip?lito Unanue. Lima, Per?. 9 Sociedad Peruana de Enfermedades Infecciosas y Tropicales. Lima, Per?. 10 Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia. Lima, Per?.
[h=3]Abstract[/h] in English, Spanish
The importance of surveilling the circulation of the influenza virus and timely vaccination of different populations in Peru was analyzed in three sessions by a group of clinical experts from different specialties. The Peruvian national influenza surveillance system has many selected establishments that have become currently ineffective in terms of a timely report. Most of the samples come from Lima. The viral distribution is inadequately analyzed. The northern and jungle areas of the country have weather and season conditions different to those in Lima and on the southern highlands. This lack of coordination is accentuated by the opportunity of arrival of the influenza vaccine in the country. The Ministry of Health uses a trivalent vaccine but the possibility of a tetravalent vaccine with the two type-B lineages must be analyzed from a cost-benefit standpoint. The appropriateness of vaccinating two times a year, regionally, should be assessed.
PMID: 31800947 DOI: 10.17843/rpmesp.2019.363.4481